Apoptosis regulatory protein (None)

Apoptosis regulatory proteins are a functional group of molecules that control the balance of cell survival and programmed cell death (apoptosis). The group encompasses several major families, notably the Bcl-2 family (which governs the intrinsic, or mitochondrial, pathway by regulating mitochondrial membrane permeability) and the Inhibitor of Apoptosis Proteins (IAPs, which suppress caspase activation in both intrinsic and extrinsic pathways). These proteins play pivotal physiological roles in development, homeostasis, and immune responses and are strongly implicated in the pathogenesis of cancer and other diseases characterized by aberrant cell survival or death. Dysregulation or mutation of these proteins can contribute to treatment resistance and disease progression, making individual members of these families validated targets for anticancer therapy. However, “apoptosis regulatory proteins” as stated does not refer to a unique protein and should be replaced with a specific protein or protein family name for structured analysis.

Other names

Apoptosis regulatorsBcl-2 family proteins (e.g., Bcl-2, Bcl-xL, Bax, Bak, Bad, Bim, Bid, Puma)Inhibitor of apoptosis proteins (IAPs; e.g., XIAP, c-IAP1, c-IAP2, survivin)Pro-apoptotic proteinsAnti-apoptotic proteinsMitochondrial apoptosis regulators

Small molecules can inhibit anti-apoptotic Bcl-2 family proteins, promoting apoptosis by restoring mitochondrial outer membrane permeabilization. IAP antagonists (e.g., SMAC mimetics) restore caspase activity, thereby enhancing execution of apoptosis in cancer cells. Some combinations induce apoptosis by dual targeting of Bcl-2 family and other survival pathways (e.g., PI3K/MEK/Bcl-xL combinations).